Market by Therapy Type, Type of Disease, Route of Administration, and Country | Forecast 2021-2028
Triton’s research report predicts that the hormone replacement therapy market in the Middle East and Africa is likely to register growth at a compound annual growth rate of 7.43% through the estimated years of 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries considered for analysis in this market are:
• The United Arab Emirates
• Turkey
• South Africa
• Saudi Arabia
• Rest of Middle East & Africa
Enhancements
in the healthcare infrastructure are estimated to amplify the demand for
hormone replacement therapy in the region’s countries, including Saudi Arabia,
Qatar, and others. Furthermore, governments are taking initiatives as directed
by the WHO or other organizations, which further supports the growth of the
hormone replacement therapy market in Middle East and Africa region.
A
significant number of Saudi Arabia women are considered to prefer hormone
replacement therapy as an ideal method to treat menopausal symptoms.
Additionally, the number of women suffering from breast cancer is increasing
rapidly and is among the leading causes of death each year. Hormone therapy is
known to be used only for breast cancers with receptors for the biologically
occurring hormones, estrogen, or progesterone. Hence, as mentioned above, these
factors majorly add to the development of the hormone replacement therapy
market across Saudi Arabia.
Furthermore,
the UAE is among the significant destinations for health tourists seeking
quality hormone replacement therapy treatment. Moreover, it is considered to be
a hub for enhanced healthcare services, offering hormone replacement therapy at
an affordable cost. Along with this, the price of this therapy is relatively
less compared to the US and European countries, propelling the hormone
replacement therapy market on a positive growth trajectory.
Teva
Pharmaceutical Industries Ltd is a pharmaceutical company focusing on
developing, manufacturing, and marketing generic, branded, and active
pharmaceuticals. Among its popular products is testosterone gel 1.62% CIII,
which is used for replacement therapy in adult males to treat conditions
related to the absence of endogenous testosterone. It offers its products to
various end-users and is headquartered in Israel.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
2.2. KEY
INSIGHTS
2.2.1. INTRODUCTION
OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT
2.2.2. MODERN
SEDENTARY LIFESTYLES
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
STRATEGIC DEVELOPMENTS
2.6.1. ACQUISITIONS
& MERGERS
2.6.2. PRODUCT
LAUNCH & DEVELOPMENTS
2.6.3. CONTRACTS
AND PARTNERSHIPS
2.6.4. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE
2.7.2. INCREASE
IN PREVALENCE OF HORMONAL DISORDERS
2.7.3. NEW
PRODUCT LAUNCHES BY MAJOR GIANTS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST OF TREATMENT
2.8.2. ADVERSE
REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
2.9. MARKET
OPPORTUNITIES
2.9.1. AVAILABILITY
OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH
2.9.2. LAUNCH
OF TELEMEDICINE CLINICAL PRACTICE SERVICES
3. MIDDLE
EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE
3.1. ESTROGEN
HORMONE REPLACEMENT THERAPY
3.2. THYROID
HORMONE REPLACEMENT THERAPY
3.3. TESTOSTERONE
HORMONE REPLACEMENT THERAPY
3.4. HUMAN
GROWTH HORMONE REPLACEMENT THERAPY
3.5. PROGESTOGEN
HORMONE REPLACEMENT THERAPY
4. MIDDLE
EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE
4.1. MENOPAUSE
4.2. MALE
HYPOGONADISM
4.3. GROWTH
HORMONE DEFICIENCY
4.4. HYPOTHYROIDISM
4.5. OTHER
TYPE OF DISEASES
5. MIDDLE
EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION
5.1. ORAL
5.2. PARENTERAL
5.3. TRANSDERMAL
5.4. OTHER
ROUTES OF ADMINISTRATION
6. MIDDLE
EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET – COUNTRY OUTLOOK
6.1.1. SAUDI
ARABIA
6.1.2. UNITED
ARAB EMIRATES
6.1.3. TURKEY
6.1.4. SOUTH
AFRICA
6.1.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. AMGEN
7.3. ANI
PHARMACEUTICALS
7.4. BAYER
AG
7.5. DR
REDDY’S LABORATORIES LTD
7.6. ELI
LILLY & COMPANY
7.7. GENENTECH
INC
7.8. IPSEN
7.9. MERCK
KGAA
7.10. NOVARTIS
AG
7.11. NOVEN
PHARMACEUTICALS INC
7.12. NOVO
NORDISK A/S
7.13. PFIZER
INC
7.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
7.15. VIATRIS
INC (MYLAN NV)
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS & MERGERS
TABLE 4: LIST OF PRODUCT LAUNCHES &
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 6: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 7: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)
TABLE 8: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)
TABLE 9: MIDDLE EAST AND AFRICA HORMONE
REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $
MILLION)
FIGURE 1: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)
FIGURE 3: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 4: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 5: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT
THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT
THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 7: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY,
2021-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)
FIGURE 9: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)
FIGURE 10: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $
MILLION)
FIGURE 11: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN
$ MILLION)
FIGURE 12: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $
MILLION)
FIGURE 14: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028
(IN %)
FIGURE 15: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 16: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)
FIGURE 17: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST AND AFRICA
HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION,
2021-2028 (IN $ MILLION)
FIGURE 19: SAUDI ARABIA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: UNITED ARAB EMIRATES
HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: TURKEY HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: SOUTH AFRICA HORMONE
REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: REST OF MIDDLE EAST &
AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)